American Vietnamese Biotech Incorporation Balance Sheet Health
Financial Health criteria checks 4/6
American Vietnamese Biotech Incorporation has a total shareholder equity of ₫1,626.1B and total debt of ₫153.1B, which brings its debt-to-equity ratio to 9.4%. Its total assets and total liabilities are ₫1,897.1B and ₫271.0B respectively.
Key information
9.4%
Debt to equity ratio
₫153.13b
Debt
| Interest coverage ratio | n/a |
| Cash | ₫19.87b |
| Equity | ₫1.63t |
| Total liabilities | ₫271.01b |
| Total assets | ₫1.90t |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: AMV's short term assets (₫1,036.4B) exceed its short term liabilities (₫144.5B).
Long Term Liabilities: AMV's short term assets (₫1,036.4B) exceed its long term liabilities (₫126.5B).
Debt to Equity History and Analysis
Debt Level: AMV's net debt to equity ratio (8.2%) is considered satisfactory.
Reducing Debt: AMV's debt to equity ratio has increased from 1.6% to 9.4% over the past 5 years.
Debt Coverage: AMV's debt is well covered by operating cash flow (230.8%).
Interest Coverage: Insufficient data to determine if AMV's interest payments on its debt are well covered by EBIT.